• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mycobacterium tuberculosis: 2014 Clinical trials in review.

作者信息

Laupland Kevin B, Valiquette Louis

机构信息

Department of Medicine, Royal Inland Hospital, Kamloops, British Columbia; ; Departments of Medicine, Critical Care Medicine, Pathology and Laboratory Medicine, and Community Health Sciences, University of Calgary, Calgary, Alberta;

Department of Microbiology-Infectious Diseases, Université de Sherbrooke, Sherbrooke, Quebec.

出版信息

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):11-4. doi: 10.1155/2015/984635.

DOI:10.1155/2015/984635
PMID:25798148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4353263/
Abstract
摘要

相似文献

1
Mycobacterium tuberculosis: 2014 Clinical trials in review.结核分枝杆菌：2014年临床试验综述
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):11-4. doi: 10.1155/2015/984635.
2
Mycobacterium vaccae immunotherapy for treating tuberculosis.
Cochrane Database Syst Rev. 2001(1):CD001166. doi: 10.1002/14651858.CD001166.
3
Mycobacterium vaccae immunotherapy for treating tuberculosis.
Cochrane Database Syst Rev. 2003(1):CD001166. doi: 10.1002/14651858.CD001166.
4
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.母牛分枝杆菌免疫疗法治疗结核病
Front Biosci. 2004 May 1;9:1701-19. doi: 10.2741/1292.
5
[Recent progress in mycobacteriology].[分枝杆菌学的最新进展]
Kekkaku. 2007 Oct;82(10):783-99.
6
Novel vaccine candidates against Mycobacterium tuberculosis.针对结核分枝杆菌的新型疫苗候选物。
Int J Biol Macromol. 2018 Dec;120(Pt A):180-188. doi: 10.1016/j.ijbiomac.2018.08.037. Epub 2018 Aug 9.
7
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?牛分枝杆菌卡介苗（BCG）疫苗的多样性及接种前景：为何BCG无法预防结核病？
Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28.
8
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Kekkaku. 1999 May;74(5):447-52.
9
[Genomics and gene engineering: rationale to the development of new means of tuberculosis control].[基因组学与基因工程：结核病控制新方法发展的理论依据]
Zh Mikrobiol Epidemiol Immunobiol. 2004 Jul-Aug(4):94-101.
10
Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis.从关于非洲分枝杆菌的流行病学、临床和免疫学研究中学习，以增进目前对宿主-病原体相互作用的理解，并用于开发和评估结核病的诊断方法、宿主导向疗法及疫苗。
Int J Infect Dis. 2017 Mar;56:126-129. doi: 10.1016/j.ijid.2016.12.003. Epub 2016 Dec 12.

引用本文的文献

1
Identification of Mycobacterium tuberculosis isolated from culture-negative pulmonary and extra-pulmonary samples in cases of suspected tuberculosis.在疑似结核病病例中，从培养阴性的肺部和肺外样本中鉴定结核分枝杆菌。
GMS Hyg Infect Control. 2019 Aug 5;14:Doc09. doi: 10.3205/dgkh000325. eCollection 2019.

本文引用的文献

1
CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.延迟抗逆转录病毒治疗会导致CD4细胞缺乏和结核病风险持续存在：来自CIPRA HT-001的5年数据。
Int J Tuberc Lung Dis. 2015 Jan;19(1):50-7. doi: 10.5588/ijtld.14.0217.
2
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial.H1/IC31®（一种含佐剂的结核亚单位疫苗）在CD4 +淋巴细胞计数大于350个细胞/mm3的HIV感染成人中的安全性和免疫原性：一项II期、多中心、双盲、随机、安慰剂对照试验。
PLoS One. 2014 Dec 9;9(12):e114602. doi: 10.1371/journal.pone.0114602. eCollection 2014.
3
Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.在巴西用Xpert MTB/RIF取代涂片显微镜检查诊断结核病的影响：一项阶梯式楔形整群随机试验
PLoS Med. 2014 Dec 9;11(12):e1001766. doi: 10.1371/journal.pmed.1001766. eCollection 2014 Dec.
4
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.每日使用利福喷汀治疗肺结核。一项随机、剂量范围试验。
Am J Respir Crit Care Med. 2015 Feb 1;191(3):333-43. doi: 10.1164/rccm.201410-1843OC.
5
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.在接受基于洛匹那韦/利托那韦的抗逆转录病毒治疗的非洲HIV感染结核病患者中，对不同利福布汀剂量进行随机药代动力学评估。
BMC Pharmacol Toxicol. 2014 Nov 19;15:61. doi: 10.1186/2050-6511-15-61.
6
The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.抗逆转录病毒疗法对HIV阳性患者结核病治疗期间死亡率的影响：一项系统评价和荟萃分析。
PLoS One. 2014 Nov 12;9(11):e112017. doi: 10.1371/journal.pone.0112017. eCollection 2014.
7
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.高剂量利福喷汀联合莫西沙星治疗肺结核
N Engl J Med. 2014 Oct 23;371(17):1599-608. doi: 10.1056/NEJMoa1314210.
8
A four-month gatifloxacin-containing regimen for treating tuberculosis.含加替沙星的四个月疗程治疗结核病。
N Engl J Med. 2014 Oct 23;371(17):1588-98. doi: 10.1056/NEJMoa1315817.
9
Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.结核感染T细胞检测金标法：在西非科特迪瓦对CD4计数高的HIV感染成人排除活动性结核的效能。
PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.
10
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.基于莫西沙星的四个月疗程用于治疗药物敏感型肺结核。
N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7.